Cite
HARVARD Citation
Kanjanapan, Y. et al. (2019). Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities. Cancer. 125 (8), pp. 1341-1349. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kanjanapan, Y. et al. (2019). Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities. Cancer. 125 (8), pp. 1341-1349. [Online].